Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc. (NYSE: INSP) is a medical technology company focused on developing and commercializing minimally invasive solutions for patients with obstructive sleep apnea. The company's website is located at InspireSleep.com. From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Inspire Medical Systems, Inc. does
In the company’s own words
Inspire Medical Systems, Inc. (NYSE: INSP) is a medical technology company focused on developing and commercializing minimally invasive solutions for patients with obstructive sleep apnea. The company's website is located at InspireSleep.com.
The company's core product is the Inspire system, a proprietary closed-loop neurostimulation technology that represents the first FDA-approved treatment of its kind for moderate to severe obstructive sleep apnea. The Inspire system consists of implantable components including a neurostimulator, stimulation lead, and respiratory sensing capability, along with a patient remote control. The device delivers mild electrical stimulation to the hypoglossal nerve to maintain an open airway during sleep. Physicians have treated more than 125,000 patients with Inspire therapy across the United States, Europe, and Asia.
Inspire operates through a direct sales organization in the U.S. and select European markets, with 295 U.S. sales territories and 21 territories outside the U.S. as of December 31, 2025. The company also sells through distributors in Japan, Singapore, Hong Kong, and Thailand. The company maintains a dedicated market access team focused on reimbursement, prior authorization, coding, and coverage with third-party payors.
The Inspire system received FDA premarket approval in 2014 and has been commercially available in certain European markets since 2011. Japan's Ministry of Health, Labour and Welfare approved the therapy in 2018. In 2024, the company received FDA approval for the Inspire V neurostimulator, which it began marketing in 2025. The company also received expanded FDA indications in 2023 for pediatric patients with Down syndrome and increased the upper AHI limit to 100 events per hour.
Clinical evidence supporting the Inspire system includes the STAR trial published in the New England Journal of Medicine, more than 385 peer-reviewed publications, and the ADHERE global patient registry which achieved its target enrollment of 5,000 patients in 2024. The company maintains a comprehensive intellectual property portfolio with 119 issued U.S. patents and 83 issued foreign patents as of December 31, 2025.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- GOLDEN VALLEY, MN
- Fiscal year end
- December
- CIK
- 1609550
- SIC
- 3841
Financial performance, year by year
Fiscal 2018–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Inspire Medical Systems, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Inspire Medical Systems, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Inspire Medical Systems, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Inspire Medical Systems, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Inspire Medical Systems, Inc.'s last four quarterly filings that the numbers alone won't show?”